image
Healthcare - Biotechnology - NASDAQ - US
$ 1.06
-2.75 %
$ 95.5 M
Market Cap
-0.86
P/E
BALANCE SHEET
54.3 M ASSETS
-57.50%
25.4 M LIABILITIES
80.31%
28.9 M EQUITY
-74.55%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Immunic, Inc.
image
Current Assets 52.5 M
Cash & Short-Term Investments 46.7 M
Receivables 0
Other Current Assets 5.86 M
Non-Current Assets 1.76 M
Long-Term Investments 0
PP&E 1.76 M
Other Non-Current Assets 0
Current Liabilities 24.7 M
Accounts Payable 5.1 M
Short-Term Debt 695 K
Other Current Liabilities 18.9 M
Non-Current Liabilities 639 K
Long-Term Debt 639 K
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
ASSETS
Cash & Cash Equivalents 46.7 106.7 86.9 127.5 29.4 13.3 56.9 60.0 83.4 102.2 38.2 4.5 0.8
Short Term Investments 0 9.6 0 0 0 0 0 0 0 0 0 14.0 0
Receivables 0 0 0 0 0 0 0 0 0 0 0 0 0
Inventory 0 (2.7) (2.1) 3.4 (0.4) (0.2) 0 0 0 0 0 0 0
Other Current Assets 5.9 9.5 18.1 6.3 2.9 0.9 1.2 1.5 1.7 2.6 4.7 0.7 86 K
Total Current Assets 52.5 125.9 105.0 133.7 32.2 14.2 58.1 61.5 85.1 104.8 43.9 19.1 0.9
PP&E 1.8 1.8 1.1 1.1 0.7 0.7 2.2 2.5 3.8 3.1 2.5 1.2 1.1
Intangible Assets 0 0 33.0 33.0 33.0 0 0 3.1 0 0 0 0 0
Goodwill 0 0 33.0 33.0 33.0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0 43 K 42 K 42 K 42 K 37 K 0.1 (3.0) 0.2 0.2 0.3 0 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 54.3 127.8 139.1 167.9 66.0 15.0 60.4 64.0 89.1 108.1 46.6 20.3 2.0
LIABILITIES
Accounts Payable 5.1 4.3 3.7 3.7 2.4 0.3 1.0 0.8 1.2 1.2 1.2 1.1 0.9
Short Term Debt 0.7 0.6 0.4 0.3 0 0 0 0 0 0 0 0 0.5
Other Current Liabilities 18.9 8.2 7.2 4.4 3.6 2.2 9.2 4.7 5.4 9.1 3.5 0.6 0.6
Total Current Liabilities 24.7 13.1 11.4 8.4 7.1 2.5 10.3 5.5 6.7 10.3 4.8 1.7 2.0
Long Term Debt 0.6 1.0 0.6 0.7 0.5 0 0 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 41 K 59 K 100 K 0.1 0.2 0.3 26.2 54.8
Total Liabilities 25.4 14.1 12.0 9.1 7.6 2.6 10.3 5.6 6.8 10.5 5.2 28.0 56.8
EQUITY
Common Stock 4 K 4 K 3 K 2 K 1 K 4 K 4 K 3 K 3 K 2 K 1 K 0 0
Retained Earnings (410.9) (317.3) (196.9) (103.9) (59.9) (337.4) (296.0) (243.8) (202.9) 97.6 (103.2) (70.4) (63.7)
Other Accumulative Comprehensive Income/Loss 3.8 3.0 (0.3) (4.1) (1.4) 80 K 78 K 83 K 80 K 89 K 96 K 88 K 83 K
Total Equity 28.9 113.7 127.1 158.8 58.4 12.4 50.0 58.4 82.3 97.6 41.4 (7.6) (54.9)
Total Liabilities and Equity 54.3 127.8 139.1 167.9 66.0 15.0 60.4 64.0 89.1 108.1 46.6 20.3 2.0
SHARES OUTSTANDING
Common Shares Outstanding 44.3 31.8 23.7 15.7 7.7 1.1 1.0 0.8 0.6 0.6 14.1 K 14.1 K 14.1 K